MedTrace Logo

Volumetric Integral Phase-shift Spectroscopy for Noninvasive Detection of Hemispheric Bioimpedance Asymmetry in Acute Brain Pathology

NCT03148340 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 287

Last updated 2018-12-12

No results posted yet for this study

Summary

The purpose of this study is to assess the ability of the Fluids Monitor to detect hemispheric bioimpedance asymmetry associated with acute brain pathology in patients presenting with suspected Acute Ischemic Stroke (AIS).

Conditions

  • Stroke
  • Stroke, Acute
  • Ischemic Stroke
  • Hemorrhage
  • Clot (Blood); Brain
  • Subarachnoid Hemorrhage
  • Cerebral Infarction
  • Cerebral Hemorrhage
  • Cerebral Stroke
  • Intracerebral Hemorrhage
  • Intracerebral Injury

Interventions

DIAGNOSTIC_TEST

VIPS Monitoring

Bioimpedance asymmetry

Sponsors & Collaborators

  • Cerebrotech Medical Systems, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-14
Primary Completion
2018-05-10
Completion
2018-07-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03148340 on ClinicalTrials.gov